Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can eating only between 8 AM and 4 PM help women with PCOS?

NCT ID NCT06807775

Disease control Sponsor: Hacettepe University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether limiting food intake to an 8-hour window each day (16:8 time-restricted feeding) can improve weight, blood sugar, and appetite-related hormones in women with polycystic ovary syndrome (PCOS). Forty-five women will be split into three groups: two PCOS groups (one on time-restricted eating, one on a standard calorie-restricted diet) and a healthy control group on time-restricted eating. The trial lasts 12 weeks and tracks changes in body mass index, blood markers, and food cravings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
time-restricted feeding (16:8 model)
What this could lead to
If successful, this could offer a simple, non-drug way to improve weight, metabolism, and appetite control in women with PCOS.
What could go wrong
This is a small early-phase study (45 participants) comparing two dietary approaches, so results may not apply widely. Adherence to the strict eating window may be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 45 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 35 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * For study groups of women diagnosed with polycystic ovary syndrome (PCOS) * Aged between 19 and 35 years, with a diagnosis of PCOS * No chronic diseases diagnosed by a physician, other than PCOS * Body mass index (BMI) between 25 and 40 kg/m² * No use of oral contraceptives, insulin sensitizers, or anti-androgen medications in the last three months * For the healthy control group * Aged between 19 and 35 years * No diagnosis of chronic diseases * Body mass index (BMI) between 25 and 40 kg/m² * No use of oral contraceptives, insulin sensitizers, or anti-androgen medications in the last three months Exclusion Criteria: * For all study groups: * Being in the menopause, pregnancy, or lactation period * Having a diagnosis of any chronic disease (e.g., hypertension, diabetes mellitus, cardiovascular disease, etc.) other than PCOS, as determined by a physician * Having hyperprolactinemia, congenital adrenal hyperplasia, androgen-secreting tumors, thyroid disorders, Cushing's syndrome, hepatic or renal dysfunction * Using antihyperlipidemic, antihypertensive, or glucocorticoid medications * Following any specific dietary treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Polycystic ovarian syndrome (PCOS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Polycystic ovarian syndrome (PCOS)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.